Related references
Note: Only part of the references are listed.Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria
William T. Barker et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to Colistin
Bradley M. Minrovic et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
Nicola Petrosillo et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria
William M. Huggins et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Few novel antibiotics in the pipeline, WHO warns
Zosia Kmietowicz
BMJ-BRITISH MEDICAL JOURNAL (2017)
Few novel antibiotics in the pipeline, WHO warns
Zosia Kmietowicz
BMJ-BRITISH MEDICAL JOURNAL (2017)
The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
Roberta J. Melander et al.
ACS INFECTIOUS DISEASES (2017)
Reaction: Broad-Spectrum Antibiotics, a Call for Chemists
Michelle F. Richter et al.
CHEM (2017)
Second generation modifiers of colistin resistance show enhanced activity and lower inherent toxicity
Christopher M. Brackett et al.
TETRAHEDRON (2016)
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Gerard D. Wright
TRENDS IN MICROBIOLOGY (2016)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Abiola O. Olaitan et al.
FRONTIERS IN MICROBIOLOGY (2014)
Unique Structural Modifications Are Present in the Lipopolysaccharide from Colistin-Resistant Strains of Acinetobacter baumannii
Mark R. Pelletier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
How Does Colistin-Induced Nephropathy Develop and Can It Be Treated?
Gulsum Ozkan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors
Sunghyun Kang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Angela M. Caliendo et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
2-Aminopyrimidine as a novel scaffold for biofilm modulation
Erick A. Lindsey et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
